NextEra, Danaher, Rhythm Pharmaceuticals and more

Take a look at the businesses making headlines after hours.

NextEra Vitality — Shares fell 3% in prolonged buying and selling after the corporate introduced its intent to promote $2 billion in fairness models. Every fairness unit will probably be issued within the quantity of $50 and can encompass a contract to buy NextEra Vitality widespread inventory sooner or later, in addition to a 5% undivided helpful possession curiosity in a NextEra Vitality Capital Holdings debenture due Sept. 1, 2027, issued within the principal quantity of $1,000.

Danaher — The medical firm noticed shares rise 4% after asserting plans to spin off its environmental and utilized options enterprise to create an impartial, publicly traded firm. It additionally raised its third-quarter income steering, in keeping with FactSet.

Rhythm Prescribed drugs — Shares of Rhythm Prescribed drugs fell about 11% after the corporate introduced a $100 million inventory providing.

Arconic Corp — The manufacturing firm’s shares slid about 8% after Arconic offered a lower-than-previously-expected income forecast for the total yr, citing the affect of operational points and the mix of demand declines and better unhedged power prices in Europe.